This Article Full Text Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Services Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Reprints and Permissions Copyright Information Books from ASM Press MicrobeWorld Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Beck, I. A. Articles by Frenkel, L. M. Search for Related Content PubMed PubMed Citation Articles by Beck, I. A. Articles by Frenkel, L. M.

 Previous Article  |  Next Article 

Journal of Clinical Microbiology, April 2002, p. 1413-1419, Vol. 40, No. 4
0095-1137/02/$04.00+0     DOI: 10.1128/JCM.40.4.1413-1419.2002
Copyright © 2002, American Society for Microbiology. All Rights Reserved.

Rapid and Sensitive Oligonucleotide Ligation Assay for Detection of Mutations in Human Immunodeficiency Virus Type 1 Associated with High-Level Resistance to Protease Inhibitors

Departments of Pediatrics,¹ Laboratory Medicine, University of Washington, Seattle, Washington²

Received 18 September 2001/ Returned for modification 26 November 2001/ Accepted 23 January 2002

A sensitive, specific, and high-throughput oligonucleotide ligation assay (OLA) for the detection of genotypic human immunodeficiency virus type 1 (HIV-1) resistance to Food and Drug Administration-approved protease inhibitors was developed and evaluated. This ligation-based assay uses differentially modified oligonucleotides specific for wild-type or mutant sequences, allowing sensitive and simple detection of both genotypes in a single well of a microtiter plate. Oligonucleotides were designed to detect primary mutations associated with high-level resistance to amprenavir, nelfinavir, indinavir, ritonavir, saquinavir, and lopinavir, including amino acid substitutions D30N, I50V, V82A/S/T, I84V, N88D, and L90M. Plasma HIV-1 RNA from 54 infected patients was amplified by reverse transcription-PCR and sequenced by using dideoxynucleotide chain terminators for evaluation of mutations associated with drug resistance. These same amplicons were genotyped by the OLA at positions 30, 50, 82, 88, 84, and 90 for a total of 312 codons. The sensitivity of detection of drug-resistant genotypes was 96.7% (87 of 90 mutant codons) in the OLA compared to 92.2% (83 of 90) in consensus sequencing, presumably due to the increased sensitivity of the OLA. The OLA detected genetic subpopulations more often than sequencing, detecting 30 mixtures of mutant and wild-type sequences and two mixtures of drug-resistant sequences compared to 15 detected by DNA sequencing. Reproducible and semiquantitative detection of the mutant and the wild-type genomes by the OLA was observed by analysis of wild-type and mutant plasmid mixtures containing as little as 5% of either genotype in a background of the opposite genome. This rapid, simple, economical, and highly sensitive assay provides a practical alternative to dideoxy sequencing for genotypic evaluation of HIV-1 resistance to antiretrovirals.

This article has been cited by other articles:

• Mendy, M. E., Kaye, S., Le Roux, E., Kirk, G. D., Jeng-Barry, A., McConkey, S., Cotten, M., Kuniholm, M. H., Leligdowicz, A., Hainaut, P., Rowland-Jones, S., Whittle, H. (2008). Application of a Novel, Rapid, and Sensitive Oligonucleotide Ligation Assay for Detection of Cancer-Predicting Mutations in the Precore and Basal Core Promoter of Hepatitis B Virus. J. Clin. Microbiol. 46: 2723-2730 [Abstract] [Full Text]  
• Lalonde, M. S., Troyer, R. M., Syed, A. R., Bulime, S., Demers, K., Bajunirwe, F., Arts, E. J. (2007). Sensitive Oligonucleotide Ligation Assay for Low-Level Detection of Nevirapine Resistance Mutations in Human Immunodeficiency Virus Type 1 Quasispecies. J. Clin. Microbiol. 45: 2604-2615 [Abstract] [Full Text]  
• Jallow, S., Kaye, S., Schutten, M., Brandin, E., Albert, J., McConkey, S. J., Corrah, T., Whittle, H., Vanham, G., Rowland-Jones, S., Janssens, W. (2007). Development and Evaluation of an Oligonucleotide Ligation Assay for Detection of Drug Resistance-Associated Mutations in the Human Immunodeficiency Virus Type 2 pol Gene. J. Clin. Microbiol. 45: 1565-1571 [Abstract] [Full Text]  
• Vega, Y., Perez-Alvarez, L., Delgado, E., Munoz, M., Casado, G., Carmona, R., Sierra, M., Vazquez de Parga, E., Pinilla, M., Garcia, V., Medrano, L., Contreras, G., Thomson, M., Najera, R. (2005). Oligonucleotide Ligation Assay for Detection of Mutations Associated with Reverse Transcriptase and Protease Inhibitor Resistance in Non-B Subtypes and Recombinant Forms of Human Immunodeficiency Virus Type 1. J. Clin. Microbiol. 43: 5301-5304 [Abstract] [Full Text]  
• Ellis, G. M., Mahalanabis, M., Beck, I. A., Pepper, G., Wright, A., Hamilton, S., Holte, S., Naugler, W. E., Pawluk, D. M., Li, C.-C., Frenkel, L. M. (2004). Comparison of Oligonucleotide Ligation Assay and Consensus Sequencing for Detection of Drug-Resistant Mutants of Human Immunodeficiency Virus Type 1 in Peripheral Blood Mononuclear Cells and Plasma. J. Clin. Microbiol. 42: 3670-3674 [Abstract] [Full Text]  
• Frenkel, L. M., Wang, Y., Learn, G. H., McKernan, J. L., Ellis, G. M., Mohan, K. M., Holte, S. E., De Vange, S. M., Pawluk, D. M., Melvin, A. J., Lewis, P. F., Heath, L. M., Beck, I. A., Mahalanabis, M., Naugler, W. E., Tobin, N. H., Mullins, J. I. (2003). Multiple Viral Genetic Analyses Detect Low-Level Human Immunodeficiency Virus Type 1 Replication during Effective Highly Active Antiretroviral Therapy. J. Virol. 77: 5721-5730 [Abstract] [Full Text]  
• Garcia-Lerma, J. G., Heneine, W. (2002). Rapid biochemical assays for phenotypic drug resistance testing of HIV-1. J Antimicrob Chemother 50: 771-774 [Full Text]